In addition, emerging evidence suggests that the Fbw7-PLK1 axis regulates the response to paclitaxel because loss of Fbw7 and accumulation of PLK1 promote paclitaxel resistance in breast cancer [42]. Here, PLK1 is linked to breast carcinoma.